To prepare for national introduction of a pneumococcal conjugate vaccine of restricted valency, we studied nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants.
In developing countries, pneumonia accounts for ∼30% of deaths in children !5 years of age. It is believed that many of these deaths are caused by Streptococcus pneumoniae and could be prevented by vaccination [1] . Polysaccharide protein conjugate vaccines have shown a high level of efficacy against invasive pneumococcal disease in children in the United States [2, 3] , South Africa [4] , and The Gambia [5] . The routine use of a 7-valent pneumococcal conjugate vaccine (Prevenar; Wyeth), containing serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F, has led to a marked decrease in the incidence of invasive pneumococcal disease in the United States [6] . This has been accompanied by a reduction in colonization of the nasopharynx by pneumococci of vaccine serotype [7] . However, some replacement colonization with pneumococci of non-vaccine-related serotypes has occurred, and there has been a significant increase in the incidence of invasive pneumococcal disease due to these organisms [8] [9] [10] [11] .
The Gambia intends to introduce a 7-valent pneumococcal conjugate vaccine into the country's routine vaccination schedule in the near future. It will be essential to monitor the impact of national vaccination with this vaccine of limited valency on the pattern of pneumococcal infection in the country. To facilitate this process, we have undertaken a number of background epidemiological studies prior to vaccine introduction. We have documented the serotype and serogroup dis-tribution and the molecular properties of pneumococcal isolates obtained from patients with invasive disease [12] . Furthermore, we have performed a series of carriage studies in Gambian villages to provide the baseline data that will allow the impact of routine vaccination on carriage to be determined. The first of these studies, a cross-sectional survey of the prevalence of pneumococcal carriage in 21 Gambian villages, showed a very high carriage rate across all age groups and the large reservoir of pneumococci of nonvaccine serotypes that will require close monitoring [13] . Here, we present the results of a longitudinal study of pneumococcal acquisition and carriage in Gambian infants from these villages.
PATIENTS AND METHODS
Study population. Twenty-one villages in Western Division, The Gambia, were selected for the study, as described elsewhere [13] . The prevalence of HIV infection in this population is 2%-3% [14] . We contracted a village reporter in each village who notified the study field team of all pregnancies and new births. Following collection of informed parental consent, neonates were enrolled soon after birth. A baseline survey enumerated the number of (noninfant) carriers living in the compounds of these infants.
Sampling process. Nasopharyngeal swab samples were collected as soon as possible after birth, twice monthly until 6 months of age, and at 2-month intervals until 12 months of age. Swabs were inoculated immediately into vials containing skim milk-tryptone-glucose-glycerol transport medium and placed in a cold box prior to transfer to the MRC Laboratories (a distance of 90 km) within 8 h of collection in accordance with the World Health Organization protocol for evaluation of pneumococcal carriage [15] . Inoculated vials were stored at Ϫ70ЊC until they were tested in batches by subculture onto gentamicin (5 mg/mL) sheep blood agar for isolation of S. pneumoniae.
Laboratory investigations. Pneumococci were identified by their morphological characteristics and optochin sensitivity. Semiquantitation of isolates was undertaken by plating out known volumes of diluted samples of transport medium. A sweep of the confluent growth at primary inoculum that contained several colonies was suspended in saline for serotyping. Serotyping was performed on-site, with capsular and factortyping sera (Statens Serum Institut) using the latex agglutination technique [13] . Isolates with equivocal serotype results were confirmed by the Quellung reaction.
Data management and statistical analysis. All data were double entered into an Microsoft Access database and checked for errors. Date of acquisition was defined as the midpoint between the last visit without carriage and the first visit at which a positive swab sample was obtained. Termination of a carriage episode was defined as at least 2 consecutive visits with a swab sample with a negative result. Date of termination was defined as the midpoint between the last visit with a positive swab sample result and the first visit at which a swab sample with a negative result was obtained. Survival analysis methods were used to study time to acquisition and duration of carriage, because some observations were censored. Parametric survival models that were based on the exponential, Weibull, and Gamma distributions were attempted. The Gamma distribution is very flexible in shape and includes the exponential and Weibull distributions as its special cases. For first episodes of carriage, the log-rank test was used to examine differences in time to acquisition and duration of carriage between serotypes. Median and mean values were obtained from Kaplan-Meier survival curves, with the tail of the curves extended to reach the x-axis by assuming an exponential distribution if the longest follow-up time was a censored observation. A Cox regression model was used to examine for risk factors. For analysis of the second or subsequent episodes of carriage, the conditional risk set model and robust standard errors were used, with age as the time scale [16] . A multinomial logit model was used to examine the changes in the distribution of vaccine serotypes, vaccine-related serotypes, and nonvaccine serotypes in relation to age. All statistical analyses were conducted using Stata software, version 8 (Stata Corp).
RESULTS
We recruited 237 infants from a total of 251 live births over an 18-month recruitment period; 1 infant had only 1 swab sample obtained (at birth) and was excluded. Results for the remaining 236 infants (128 [54%] of whom were male) who resided in 21 villages were included in the analysis. A total of 3145 swab samples were obtained, representing a mean of 13 samples per infant (median no. of samples per infant, 15; range, 1-18 samples per infant), and 2710 pneumococcal isolates were obtained.
All 236 infants carried pneumococci at some point during the study period; the prevalence of pneumococcal carriage was 180% in the third month of life and remained at 80%-90% after that (figure 1A). Sixteen (6.8%) of first acquisitions and 231 (10.4%) of subsequent acquisitions were of multiple serotypes. Overall, 65 serotypes were identified among the isolates, the 5 most common of which were 6B, 19F, 6A, 14, and 23F (table 1) . These serotypes accounted for just over one-half (51%) of all pneumococcal isolates. Forty-six percent of isolates belonged to serotypes covered by the currently available 7-valent vaccine, and a further 20% belonged to vaccine-related serotypes (figure 1B). Upward trends of the relative proportions of isolates of vaccine serotypes and of vaccine-related serotypes with increasing age were both statistically significant (P ! .001 for both). Figure 2 shows the survival curve, by age, for the first ac- quisition of a pneumococcal strain. The mean and median ages at first acquisition were 33 days (95% CI, 29-36 days) and 24 days (95% CI, 21-28 days), respectively. An exponential model with an acquisition rate of 3.1% (95% CI, 2.7%-3.5%) fitted the survival curve well. The rate of first acquisition appeared to be constant over age. In 16 (7%) of first acquisitions, pneumococci of 2 different serotypes were obtained. Pneumococci of serotypes 6B, 19F, 23F, 6A, 35B, or 4 were the 6 most commonly isolated pneumococci obtained at first acquisition (table  2) , which was in keeping with their predominance among all isolates. A log-rank test showed no evidence of any significant difference in acquisition rates between pneumococci of the 6 most frequently isolated serotypes ( ) or between vac-P p .067 cine serotypes, vaccine-related serotypes, or nonvaccine sero- 
types (
). However, pneumococci of serotype 4 tended P p .317 to be acquired slightly earlier than other serotypes, with a median age at first acquisition of 14 days.
Eleven infants with first-time acquisitions were censored for the analysis of duration of carriage (4 because of completion of follow-up, and 7 dropped out early from the study). Figure  3 shows the duration of first carriage for all serotypes. The distribution was skewed, with the mean and median durations being 87.6 days (95% CI, 78.2-97.0 days) and 70 days (95% CI, 59.5-77.0 days), respectively. An exponential model fitted the data significantly worse than did a Gamma model (P ! ), which itself did not follow the observed pattern very .001 closely. There were significant differences in the duration of carriage among the 6 most commonly isolated serotypes ( , by log-rank test): pneumococci of serotypes 4, 23F, P p .004 and 35B were carried for shorter periods (median durations of 42, 50.5, and 63.0 days, respectively) than were pneumococci of serotypes 6B, 6A, and 19F (median durations of 92, 94, and 98.5 days, respectively) (table 2). A log-rank test showed small but statistically insignificant differences in the duration of carriage of vaccine serotypes, vaccine-related serotypes, and nonvaccine serotypes ( ). P p .114 Individual and household variables that were considered as possible confounders for age at first acquisition and duration of first carriage included sex, ethnic group, place of delivery, number and age of members of the household, and age at acquisition of the pneumococcal strain. A high hazard ratio (HR) from the Cox regression analysis indicated a short time to acquisition or a short duration of carriage: no individual subject characteristics were identified that influenced time to first acquisition, nor was this influenced by the number of carriers in the household at the time of the initial baseline survey. Members of the Fula ethnic group had a shorter time to first acquisition than did members of other ethnic groups, although this was of borderline significance (HR, 1.95; 95% CI, 1.00-3.70;
). Delivery in hospital was associated with a P p .05 shorter duration of carriage than was home delivery (HR, 1.90; 95% CI, 1.17-3.09;
), and a high number of carriers P p .009 !5 years of age in the compound was associated with a longer duration of carriage (HR, 0.93; 95% CI, 0.87-0.99;
). P p .041 There were 909 episodes of carriage after a first episode of carriage had cleared. In contrast with the situation for first episodes of carriage, serotype 14 was among the most common serotypes found in subsequent episodes of carriage (ranked third). The 6 most common serotypes had similar rates of acquisition ( ) and duration of carriage ( ) P p .229 P p .699 (table 3) . However, nonvaccine serotypes were acquired faster (median age at acquisition, 152 days;
) and had a P p .004 shorter duration of carriage (median duration, 43 days; P ! ) than vaccine serotypes (median age at acquisition, 174 .001 days; median duration, 70 days). Controlling for covariates, having a previous episode of serotype 14 carriage was associated significantly with a reduced hazard (delayed reacquisition) of acquiring this serotype again (HR, 0.41; ) (table 4) . P p .005 However, previous carriage of serotype 14 was also associated with a longer duration of carriage of this serotype (HR, 0.48;
). Previous carriage of the other 5 most common se-P p .017 rotypes had no significant influence on the subsequent rate of reacquisition of carriage or on its duration, although 4 of the 5 strains showed a trend in the same direction as serotype 14 in both respects.
DISCUSSION
In this study, we have documented the common pneumococcal serotypes acquired in the first year of life in Gambian villagers, recorded the change in their distribution over time, and explored serotype-specific differences in first and subsequent acquisitions of S. pneumoniae. The results provide important insights and a baseline for the assessment of the effect of the introduction of 7-valent pneumococcal conjugate vaccine into the Gambian immunization schedule.
Although similar longitudinal studies undertaken in both developing and developed countries have shown that most, if not all, children are colonized with pneumococcal strains at some stage during the first 1-2 years of life [17, 18] , a striking feature of the epidemiology of pneumococcal infection in Gambian villagers is the very early age of first acquisition; the mean and median times to first acquisition were 33 days and 24 days, respectively. To our knowledge, such very early pneumococcal acquisition has been reported previously only from the highlands of Papua New Guinea, where all children had acquired S. pneumoniae by the age of 3 months [19] . Granat et al. [18] showed that 50% of infants acquired a pneumococcus by 8 weeks of age in Bangladesh. In industrialized countries, Gray et al. [17] documented a mean time to first acquisition of pneumococci of 6 months in infants in the United States, and Syrjanen et al. [20] showed that 34% of Finnish infants had been colonized by S. pneumoniae by 6 months of age and that 56% had been colonized after a year. It might be considered to be surprising that in The Gambia, a country with high breastfeeding rates, pneumococcal strains are acquired so early. However, breastfeeding has different effects on different pathogens and does not have a substantial influence on pneumococcal carriage [21] .
Almost two-thirds of the isolates identified in our study were either of a vaccine serotype or vaccine-related serotype. Serotype 19A, which does not appear to receive serogroup coverage from 19F within the 7-valent pneumococcal conjugate vaccine [22] , accounted for only 5% of isolates. Serotypes 1 and 5, which cause approximately one-third of the cases of invasive pneumococcal disease in The Gambia [12] , were isolated on only 3 and 2 occasions, respectively (data not shown).
Worldwide, only a few serotypes predominate in any particular setting. Five serotypes accounted for 51% of all episodes of carriage in The Gambia, 5 serotypes accounted for 56% of all episodes in Bangladesh, 6 serotypes accounted for 73% of all episodes in Finland, and 4 serotypes accounted for twothirds of episodes in the United States. A second outstanding feature of our study is that 65 different serotypes were isolated at some time during the first year of life. This compares with 35 different serotypes in Bangladesh, 25 different serotypes in the United States, and 30 different serotypes in Finland. Such serotype diversity so early in life is of considerable interest and NOTE. Episodes for the 6 most frequently isolated serotypes are shown, together with the number of isolates belonging to vaccine serotypes, vaccine-related serotypes, and nonvaccine serotypes. NOTE. Episodes for the 6 most frequently isolated serotypes are shown, together with the number of isolates belonging to vaccine serotypes, vaccine-related serotypes, and nonvaccine serotypes.
concern, because it signals the presence of a large reservoir of nonvaccine serotypes available for the potential replacement of vaccine types after the introduction of 7-valent pneumococcal conjugate vaccine.
Early acquisition in the majority of infants and the diversity of serotypes encountered enabled us to study serotype-specific acquisition and duration of carriage for multiple episodes of infection. The duration of carriage has been shown by others to vary by serotype [17, 23] and to generally decrease with increasing age [24] . We were able to show that, adjusted for age, previous acquisition of 1 particular serotype (serotype 14) was associated with a relative delay in acquiring this bacterium again and a longer duration of a subsequent carriage episode. Serotype 14, present in the 7-valent pneumococcal conjugate vaccine, is common in both developed and developing countries [12, 25, 26] , with a strong predilection for causing invasive disease [23, 27] , especially bacteremia [28] , and for infecting younger age groups [25] . It has been noted that duration of carriage is inversely related to invasiveness [29] . If the delay seen in reacquisition of serotype 14 after a primary episode of infection with pneumococci of this serotype was attributable to acquisition of immunity acquired as a result of the first infection, it might have been expected that this would have been reflected in a shorter duration of carriage during the second episode (and not the opposite, as was observed). This finding may have been attributable to chance, but it may reflect the complex interactions between immunity, acquisition, and duration of carriage of pneumococcal strains that are still little understood.
We found that delivery in the hospital was associated with a shorter duration of carriage and that a higher number of carriers !5 years of age in the compound was associated with a longer duration of carriage. It is possible that children born in the hospital were more likely to be exposed to antibiotics; otherwise, we are unable to offer an explanation for this finding. A possible explanation for the association of a longer duration of carriage with a high rate of carriage in child household contacts is that this reflects repeated acquisition rather than persistence of an initial infection. If this is the case, it suggests that the main source of pneumococcal carriage for infants is their young siblings, in keeping with previous observations in The Gambia and elsewhere [17, 24, 26, 30] .
Although we had extremely high compliance in this study, it is not realistic to sample more frequently than we have done; therefore, misclassification is a possible source of bias, because, for example, some apparently continuous carriage may actually be intermittent. Furthermore, a change in the frequency of sample collection at 6 months of age can create a spurious association between age and acquisition and between age and duration. Therefore, we used the Cox model with age as the time scale to nonparametrically control for the confounding effect of age without directly estimating it [16] . This study would have been enhanced by molecular fingerprinting. Molecular fingerprinting of isolates obtained from infants and their family members could help to determine, with more certainty, the origin of the pneumococcal strains acquired so early in life. This is the subject of a separate study of transmission of pneumococcal strains within and between households that is now underway in these villages. Furthermore, in an additional separate study, we will assay samples for pneumococcal antibody concentrations and correlate the results with the epidemiological characteristics of pneumococcal carriage.
The results of this study have shown that, in The Gambia, acquisition of pneumococcal strains is rapid and universal and that there are complex interactions between immunity, acquisition, and duration of carriage. Thus, the consequences of the introduction of a 7-valent pneumococcal conjugate vaccine into the national immunization program on the population dynamics of pneumococci in The Gambia could be profound. This study has provided a baseline for interpreting some of the changes that may be seen and reinforces the need to combine surveillance of invasive disease with strategic cross-sectional and longitudinal carriage studies to monitor the full effect of vaccine introduction. Such studies are planned.
